Patients who are eligible will receive both an imaging test and a novel biomarker test that measures the immune system’s response to pancreatic disease in the blood. “The earlier cancer …
Patients who are eligible will receive both an imaging test and a novel biomarker test that measures the immune system’s response to pancreatic disease in the blood. “The earlier cancer …